Structure-based design of targeted covalent inhibitors

Area of Science:

• Medicinal Chemistry
• Drug Discovery
• Pharmacology

Background:

• Covalent inhibition, once serendipitous and viewed with caution due to toxicity, is now a key area in drug discovery.
• Historical challenges with covalent inhibitors are being overcome by modern approaches.
• The field has shifted towards leveraging covalent inhibition for challenging drug targets.

Purpose of the Study:

• To introduce the fundamental concepts of covalent inhibition in drug discovery.
• To discuss the advantages and disadvantages associated with covalent inhibitor development.
• To provide a comprehensive overview of the current landscape and future directions in covalent drug discovery.

Main Methods:

• Review of historical and current covalent inhibitor strategies.
• Discussion of the design principles for targeted covalent inhibitors (TCIs).
• Overview of computational tools and methodologies for covalent drug discovery.

Main Results:

• Covalent inhibition offers a viable strategy for targets refractory to non-covalent approaches.
• TCIs can significantly improve drug potency and selectivity through targeted covalent binding.
• The field is advancing with new strategies and computational aids for successful development.

Conclusions:

• Covalent inhibition represents a powerful and increasingly important modality in modern drug discovery.
• Targeted covalent inhibitors provide a promising avenue for developing novel therapeutics.
• Further exploration of strategies and computational tools will accelerate covalent drug discovery efforts.